Literature DB >> 9834338

Portal vein thrombosis in cirrhosis with variceal hemorrhage.

M J Orloff1, M S Orloff, S L Orloff, B Girard.   

Abstract

Organized thrombus in the main trunk of the portal vein was encountered in 85 (6.5%) of 1300 patients with cirrhosis and variceal hemorrhage who underwent direct portacaval shunt (PCS). The thrombus was successfully removed with restoration of portal blood flow in all patients by phlebothrombectomy and balloon catheter extraction. Of the 85 patients, 65 were among 400 unselected patients who underwent emergency PCS (16%), and 20 were among 900 selected patients who underwent elective PCS (2%). All patients were closely followed for at least 5 years. Patients with portal vein thrombosis (PVT) had more advanced liver disease than those without PVT, reflected preoperatively in significantly higher (P < 0.01) incidences of ascites (75%), severe muscle wasting (52%), varices of very large size (94%), the hyperdynamic state (94%), severe hypersplenism with a platelet count of less than 50,000/mm3 (92%), and placement in Child's class C (52%). Side-to-side PCS reduced the portal vein-inferior vena cava pressure gradient to a mean of 23 mm saline solution in patients with PVT, similar to the marked pressure reduction obtained in patients without PVT. PCS promptly stopped variceal bleeding in all patients in the emergency PCS group. Permanent prevention of recurrent variceal bleeding was successful in 95% of patients with PVT and more than 99% of patients without PVT. Survival rates were similar in patients with and without PVT. In patients with PVT, survival rates at 30 days and 1, 5, 10, and 15 years following emergency PCS were 69%, 66%, 65%, 55%, and 51%, respectively, and following elective PCS were 95%, 90%, 70%, 65%, and 60%, respectively. Quality of life was similar in patients with and without PVT. Long-term PCS patency was demonstrated yearly in 93% of patients in the group with PVT and in 99.7% of patients without PVT. Other similarities after 5 years between patients with and without PVT, respectively, were the incidences of recurrent encephalopathy (9% vs. 8%), alcohol abstinence (61% vs. 64%), improved liver function (68% vs. 62% to 75%), and return to work (52% vs. 56% to 64%). It was concluded that in patients with cirrhosis and variceal hemorrhage it is almost always possible to remove portal vein thrombus by means of phlebothrombectomy and then perform a direct PCS with results similar to those achieved in the absence of PVT.

Entities:  

Mesh:

Year:  1997        PMID: 9834338     DOI: 10.1016/s1091-255x(97)80099-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  23 in total

1.  Portal vin thrombosis in intrahepatic block.

Authors:  C Sicot; D Sakellaridis; B Rueff; J N Maillard; J P Benhamou
Journal:  Minn Med       Date:  1971-02

2.  Cirrhosis and portal vein thrombosis.

Authors:  A Monarca; R Natangelo; E Tavani; V Azzolini
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

3.  Portacaval shunt as emergency procedure in unselected patients with alcoholic cirrhosis.

Authors:  M J Orloff; A C Charters; J G Chandler; J K Condon; D E Grambort; T R Modafferi; S E Levin; N B Brown; S C Sviokla; D G Knox
Journal:  Surg Gynecol Obstet       Date:  1975-07

4.  Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver.

Authors:  M J Orloff; M S Orloff; S L Orloff; M Rambotti; B Girard
Journal:  J Am Coll Surg       Date:  1995-03       Impact factor: 6.113

5.  Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation.

Authors:  B R Davidson; M Gibson; R Dick; A Burroughs; K Rolles
Journal:  Transplantation       Date:  1994-04-27       Impact factor: 4.939

6.  Orthotopic liver transplantation in the presence of partial or total portal vein thrombosis: problems in diagnosis and management.

Authors:  D Cherqui; C Duvoux; A Rahmouni; N Rotman; D Dhumeaux; M Julien; P L Fagniez
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

7.  Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients.

Authors:  K Okuda; K Ohnishi; K Kimura; S Matsutani; M Sumida; N Goto; H Musha; M Takashi; N Suzuki; T Shinagawa
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

8.  Prospective randomized trial of emergency portacaval shunt and emergency medical therapy in unselected cirrhotic patients with bleeding varices.

Authors:  M J Orloff; R H Bell; M S Orloff; W G Hardison; A G Greenburg
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

9.  Long-term survival after emergency portacaval shunting for bleeding varices in patients with alcoholic cirrhosis.

Authors:  M J Orloff; R H Bell
Journal:  Am J Surg       Date:  1986-01       Impact factor: 2.565

10.  Portal thrombosis in cirrhotics. A retrospective analysis.

Authors:  L Belli; F Romani; C V Sansalone; P Aseni; G Rondinara
Journal:  Ann Surg       Date:  1986-03       Impact factor: 12.969

View more
  7 in total

1.  Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States.

Authors:  Seth A Waits; Brandon M Wojcik; Shijie Cai; Amit K Mathur; Michael J Englesbe
Journal:  Liver Transpl       Date:  2011-09       Impact factor: 5.799

Review 2.  Portal vein thrombosis in liver cirrhosis.

Authors:  Filippo Luca Fimognari; Francesco Violi
Journal:  Intern Emerg Med       Date:  2008-02-15       Impact factor: 3.397

Review 3.  What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective.

Authors:  Francesca Romana Ponziani; Maria Assunta Zocco; Matteo Garcovich; Francesca D'Aversa; Davide Roccarina; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

4.  High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis.

Authors:  Korn Lertpipopmetha; Chirayu U Auewarakul
Journal:  BMC Gastroenterol       Date:  2011-06-10       Impact factor: 3.067

Review 5.  Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature.

Authors:  Xingshun Qi; Junna Dai; Man Yang; Weirong Ren; Jia Jia; Xiaozhong Guo
Journal:  Gastroenterol Res Pract       Date:  2015-02-24       Impact factor: 2.260

6.  Portal vein thrombosis; risk factors, clinical presentation and treatment.

Authors:  Kirstine K Sogaard; Lone B Astrup; Hendrik Vilstrup; Henning Gronbaek
Journal:  BMC Gastroenterol       Date:  2007-08-15       Impact factor: 3.067

7.  Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein.

Authors:  Lei Wang; Fuliang He; Zhendong Yue; Hongwei Zhao; Zhenhua Fan; Mengfei Zhao; Bin Qiu; Jiannan Yao; Qiushi Lin; Xiaoqun Dong; Fuquan Liu
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.